Curium Completes Patient Enrollment o... - Advanced Prostate...
Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule (177 Lu-PSMA I&T)
Written by
Maxone73
To view profiles and participate in discussions please or .
1 Reply
•
This means this drug will become very expensive too.
Not what you're looking for?
You may also like...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of Lutetium- 177,...
Eclipse Trial Update - Lutetium-Lu 177
SE's after the first dose.
Being part of this trial, I have no problem obtaining the Lu 177 from...
New Phase 1b (NON-randomized, dose timing) trial of Lu-177-PSMA-617 + Keytruda at UCSF announced
I know that several patients are looking for a non-randomized trial in the US. This one relies on...
Related Posts
- Lu-177-PSMA-617 VISION trial suspended temporarily for new recruiting
- New Trial of Lu-177-PSMA-617 to begin April 30, 2021.
- New randomized clinical trial of Lu-177-PSMA-617 for men who are still hormone sensitive
- Lu-177-PSMA-617 vs Jevtana (cabazitaxel): which should I do next?
- First clinical trial of Lu-177-PSMA-617 in recurrent, hormone-sensitive men
